Dry eye disease (DED) is a common multifactorial disorder that perpetuates itself in a vicious circle of inflammation, tear film instability, neurosensory abnormalities, and hyperosmolarity resulting in an ongoing immune response.
This previously recorded satellite symposium highlights the latest scientific findings on DED and the novel approaches currently under investigation to treat ocular surface disease.
Supported by an unrestricted educational grant from Oyster Point Pharma.
Upon completion of this activity, the participant should be able to:
Credit Designation Statement
Sponsored by
Evolve Medical Education LLC (Evolve) is an approved COPE administrator.
This activity, COPE Activity Number 123012, is accredited by COPE for continuing education for optometrists.
This course is approved for 1.5 hours CE.
Course #75787-AS
Activity #123012
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Kelly K. Nichols, OD, MPH, PhD, FAAO
Program Chair
Professor and Dean
University of Alabama at Birmingham School of Optometry
Birmingham, AL
Mile Brujic, OD, FAAO
Partner
Premier Vision Group
Bowling Green, OH
Leslie O’Dell, OD, FAAO
Clinical Director
Medical Optometry America
York, PA
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Kelly K. Nichols, OD, MPH, PhD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Bruder, Dompé, HanAll Bio, Kala Pharmaceuticals, Novartis, Osmotica, Oyster Point Pharma, Sight Sciences, Tarsis, Thea, and Topivent. Grant/Research: Allergan, Kala Pharmaceuticals, NIH, and Tear Science. Stock/Shareholder: Acquiom, Alcon Vision, LacriScience, and Tear Film Innovations.
Mile Brujic, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Akorn, Alcon Vision, Allergan, Bausch + Lomb Health, Blephex, Contamac, CSEye, Eyevance, Horizon Therapeutics, Kala Pharmaceuticals, Novartis, Sun Pharmaceutical Industries, VMax Vision, and Zea Vision. Speaker’s Bureau: Allergan, Bausch + Lomb Health, Kala Pharmaceuticals, Novartis, Optovue, Sun Pharmaceutical Industries, and Zea Vision. Grant/Research Support: Contamac.
Leslie O’Dell, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan, Bausch + Lomb, Dompe, Eyevance, Johnson & Johnson Vision, Kala Pharmaceuticals, Novartis, Oyster Point, Pharma, Sun Pharmaceutical Industries, Sight Sciences, and Tarsus. Speaker's Bureau: Allergan, Johnson & Johnson Vision, and Sight Sciences.
The Evolve staff and planners have no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Oyster Point Pharma.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Christina Y. Weng, MD, MBA, FASRS
Mark T. Dunbar, OD, FAAO
David A. Eichenbaum, MD, FAAO
Jaclyn Garlich, OD, FAAO
Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
John Kitchens, MD
Sara LeMay, OD
Sustaining Vision: Empowering Optometry for Tomorrow’s Retinal Care
1.00 creditArshad M. Khanani MD, MA, FASRS
Veeral Sheth, MD, MBA, FASRS, FACS
Lejla Vajzovic, MD, FASRS
